Microbiological Testing Service Market Scope
Microbiology testing services are required in many sectors across the world where the presence and growth of microorganisms such as pathogens, bacteria, yeast, and molds can have a detrimental impact on goods, processes, and human health. Food, consumer items, cosmetics and beauty products, medical equipment, fuels, drinking water, and oil exploration are just a few of the industries that use microbiology testing services.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Key Companies Profiled | Abbott Laboratories, Inc. (United States), Becton, Dickinson and Company (United States), BioMérieux (France), Bruker Corporation (United States), Charles River Laboratories International, Inc. (United States), Danaher Corporation (United States), Merck (Germany), Neogen Corporation (United States), Quidel Corporation (United States), Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (United States), Don Whitley Scientific Limited (United Kingdom), Rapid Micro Biosystems, Inc. (United States) and Vivione Biosciences, LLC (United States) |
CAGR | 5.5% |
Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Microbiological Testing Service market throughout the predicted period.
Abbott Laboratories, Inc. (United States), Becton, Dickinson and Company (United States), BioMérieux (France), Bruker Corporation (United States), Charles River Laboratories International, Inc. (United States), Danaher Corporation (United States), Merck (Germany), Neogen Corporation (United States), Quidel Corporation (United States), Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (United States), Don Whitley Scientific Limited (United Kingdom), Rapid Micro Biosystems, Inc. (United States) and Vivione Biosciences, LLC (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Gradientech (Sweden), Rqmicro AG (Switzerland) and Bactest Ltd. (United States).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Microbiological Testing Service market by Type , by Application (Clinical Disease Diagnostics, Food & Beverage testing, Pharmaceutical & Biological Drug Testing, Environmental Testing, Cosmetics and Personal Care Products Testing, Research Applications and Other) and Region with country level break-up.
On the basis of geography, the market of Microbiological Testing Service has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2023.
Market Leaders and their expansionary development strategies
In September 2020, Bruker Corporation announces the acquisition of Canopy Biosciences. This acquisition will help Bruker's portfolio in targeted multi-omics and fluorescence-based imaging methods will be enhanced. Canopy's success will be aided by Bruker's worldwide reach, complementing technology, and application expertise. Canopy offers a unique collection of solutions for a single cell, tissue, and suspended cell-based immunology and targeted proteomics discovery and validation, as well as a portfolio of complementing multi-omics services.
In August 2024,delighted to announce the launch of a dedicated Biosafety Level-2 microbiology lab within our testing facility in Phoenix, Arizona. Comprising around 4,000 square feet of the 12,000 square feet facility, the new lab will be focused on efficacy testing for hand sanitizers and antibacterial hand soaps.
“As per USFDA, as a regulatory body responsible for maintaining the safety of the nation's food supply, it's critical that the laboratory procedures used to support regulatory compliance, investigations, and enforcement actions satisfy the highest analytical performance requirements possible. The development of uniform validation requirements for all regulatory procedures used in laboratories to identify chemical and radiological pollutants, as well as microbiological pathogens, is a key step in ensuring that maintain the highest possible standards.”
Influencing Trend:
Advancement in Many Microbial and Identification Techniques to Get Accurate and Faster Result
Market Growth Drivers:
Spreading Infectious Disease by Microbes Such as Malaria, Tuberculosis, Diarrhea and Many More
Challenges:
Rapid Mutation of Microbes and Increasing Outbreak of Epidermis Laboratories Need to Adopt More Innovative Techniques is Challenge for the Microbiological Testing Service Market
Restraints:
High Investment Cost of the Set-Up of Testing and Low Benefit Ratio Will Constrain the Microbiological Testing Service Market
Opportunities:
Strict Regulations from Regulatory Bodies to Perform Microbial Testing Especially in Food and Drug Industries
Key Target Audience
Microbiological Testing Service Providers, Microbiological Testing Service Association, Microbiological Testing Service Franchise, Research and Development Institutes, Financial Institutes and Investors, Regulatory Bodies and Others